CBIO-11. NOVEL THERAPY TO TARGET PR-RECURRENT GLIOMA

BACKGROUND: Glioblastoma is a fatal infiltrative primary brain tumor, and standard care includes maximal safe surgical resection followed by radiation and Temozolomide (TMZ). Therapy-resistant residual cells persist in a latent state a long time before inevitable recurrence. Conventional radiation a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Rahman, Masum, Olson, Ian E, Saber, Rehan, Zhang, Jibo, Carlstrom, Lucas P, Sisi, Chen, Rajani, Karishma, Brown, Desmond, Parney, Ian, Sarkaria, Jann, Burns, Terry C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Cell Biology (Cell Cycle Regulation, DNA Repair/Modulation)
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650398/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.071
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia